Day: November 6, 2020

SFL Corporation Ltd. (“SFL” or the “Company”) (NYSE: SFL) plans to release its preliminary financial results for the third quarter of 2020 on Thursday, November 12, 2020.SFL plans to host a conference call and webcast for all stakeholders and interested parties on Thursday, November 12, 2020 at 10:00 AM (EST) / 4:00 PM (CET). Relevant material will be available from the Investor Relations section of the Company’s website at www.sflcorp.com on the same day.In order to listen to the presentation you may do one of the following: There will be a Q&A session after the presentation. Information on how to ask questions will be given at the beginning of the Q&A session.   A replay of the conference call will be available for seven days by dialing:SFL Corporation Ltd.Hamilton, BermudaInvestor and Analyst Contacts:Aksel Olesen,...

VANCOUVER, British Columbia, Nov. 06, 2020 (GLOBE NEWSWIRE) — DMG Blockchain Solutions Inc. (TSX-V: DMGI) (DMGGF:OTC US) (FRANKFURT:6AX) (“DMG” or the “Company”), a diversified blockchain and technology company, is pleased to announce it has added HIVE as a hosting client, and sold 1,240 M30s miners.Highlights:DMG sells 1,240 M30s miners to HIVE in an all cash transaction for USD$3.4 MillionDMG to host miners at the Company’s Christina Lake facilityDMG to soon provide detail on its strategy to achieve its self-mining goals with latest technology minersDMG is pleased to announce the sale of 1,240 M30s miners to Hive Blockchain Technologies Ltd. (TSXV: HIVE) (OTCQX: HVBTF) (FSE: HBF) (the “Company” or “HIVE”) in an all cash transaction for USD$3.4 million. Hive’s new miners will be hosted by DMG at the...

– Marked Reductions in Phe Observed at Two Doses –– Achieved Goal with Plans to Advance to Randomized, Concurrently Controlled Expansion Phase of Trial –– Webcast / Conference Call Today, November 6 at 4:30 p.m. ET –BEDFORD, Mass., Nov. 06, 2020 (GLOBE NEWSWIRE) — Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today the presentation of positive data from the dose-escalation portion of the Phase 1/2 gene therapy pheNIX clinical trial for adults with phenylketonuria (PKU). The results showed that product candidate HMI-102 was generally well-tolerated, and resulted in marked reductions in phenylalanine (Phe) and the Phe-to-tyrosine (Tyr) ratio (Phe/Tyr ratio) at two doses. Phe is a registrable endpoint in PKU, and the Phe/Tyr ratio is a clinically relevant diagnostic...

For immediate release6 November 2020EIB submits SEC Form 18-K/A Amendment No. 9European Investment Bank (EIB) has submitted its SEC Form 18-K/A Amendment No. 9.To view the document, please go to www.sec.gov.The 18-K/A has also been posted on the EIB website:https://www.eib.org/en/investor_relations/publications/eib-annual-18-k-a-report-2019-amendment-n-9.htmENDS

VANCOUVER, British Columbia, Nov. 06, 2020 (GLOBE NEWSWIRE) — Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: A2PL) („Nabis“ oder das „Unternehmen“) hat folgende Neuigkeiten zum Zivilverfahren vor dem Arizona Superior Court (das „Gericht“), das von AZ, LLC („Nabis AZ“), der hundertprozentigen Tochtergesellschaft des Unternehmens, gegen Mark Krytiuk („Krytiuk“), dem ehemaligen President, Chief Operations Officer und Director des Unternehmens, angestrengt wurde. Wie das Unternehmen bereits am 16. Oktober 2020 bekannt gab, hat Nabis AZ beim Gericht einen Antrag auf einen beschleunigten Unterlassungsanspruch gegen Krytiuk eingereicht, der sich unter anderem auf die Position von Krytiuk als Director von Perpetual Healthcare Inc. („Perpetual“), dem Betreiber der Emerald-Apotheke für medizinischen Marihuana-Einzelhandel, bezieht. Der...

 AS Pro Kapital Grupp announced on 30 September 2020 that the Management Board decided to launch the second tranche of privately placed subscriptions of unsecured, callable, fixed rate non-convertible bonds by the Company (hereinafter the “Bonds”). The announced subscription period of the bonds was 1 October 2020 – 28 October 2020.Due to technical reasons, at the request of a potential investor the Management Board of AS Pro Kapital Grupp has on 06 November 2020 decided for the second time to prolong the subscription term until 13 November 2020.AS Pro Kapital Grupp shall inform of the results of the offer with the separate notice after the decision of allocation of the Bonds is made.This notice is published in accordance with the article 7.6. of the “Requirements for Issuers” and is not an offer to subscribe the Bonds.Allan RemmelkoorMember...

Jinhua, China, Nov. 06, 2020 (GLOBE NEWSWIRE) — Kandi Technologies Group, Inc. (NASDAQ GS: KNDI) (the “Company” or “Kandi”) announced today that it will host virtual investor meetings at the Benchmark Annual Discovery One on One Conference on Wednesday, November 18, 2020.Attendance at the conference is by invitation only for clients of The Benchmark Company. Interested investors should contact your Benchmark sales representative to secure a meeting time.About Kandi Technologies Group, Inc.Kandi Technologies Group, Inc. (KNDI), headquartered in Jinhua Economic Development Zone, Zhejiang Province, is engaged in the research, development, manufacturing, and sales of various vehicular products. Kandi conducts its primary business operations through its wholly-owned subsidiary, Zhejiang Kandi Vehicles Co., Ltd. (“Kandi Vehicles”)...

BIRMINGHAM, Ala., Nov. 06, 2020 (GLOBE NEWSWIRE) — Hibbett Sports, Inc. (Nasdaq/GS: HIBB) today announced details for the release of its results for the third quarter ended October 31, 2020.Hibbett plans to issue its third quarter 2021 earnings release before the market opens on November 20, 2020, and will host a conference call later that same day at 10:00 a.m. ET.  The number to call for the live interactive teleconference is (212) 231-2939.  A replay of the conference call will be available until November 27, 2020, by dialing (402) 977‑9140 and entering the passcode, 21970559.The live broadcast of Hibbett’s quarterly conference call will be available online at www.hibbett.com under Investor Relations on November 20, 2020, beginning at 10:00 a.m. ET.  The online replay will follow shortly after the call and be available...

 AS Pro Kapital Grupp announced on 30 September 2020 that the Management Board decided to launch the second tranche of privately placed subscriptions of unsecured, callable, fixed rate non-convertible bonds by the Company (hereinafter the “Bonds”). The announced subscription period of the bonds was 1 October 2020 – 28 October 2020.Due to technical reasons, at the request of a potential investor the Management Board of AS Pro Kapital Grupp has on 06 November 2020 decided for the second time to prolong the subscription term until 13 November 2020.AS Pro Kapital Grupp shall inform of the results of the offer with the separate notice after the decision of allocation of the Bonds is made.This notice is published in accordance with the article 7.6. of the “Requirements for Issuers” and is not an offer to subscribe the Bonds.Allan RemmelkoorMember...

 AS Pro Kapital Grupp teatas 30. septembril 2020, et juhatus otsustas teises etapis pakkuda piiratud investorite ringile märkimiseks tagamata, ennetähtaegse lunastamise õigusega ja fikseeritud intressimääraga mittekonverteeritavaid võlakirju (edaspidi nimetatud kui Võlakirjad). Võlakirjade teatatud märkimisperiood oli 1. oktoober 2020 – 28. oktoober 2020.Tehnilistel põhjustel ning võimaliku investori palvel otsustas AS Pro Kapital Grupp juhatus 06. novembril 2020 teist korda pikendada võlakirjade märkimisperioodi kuni 13. novembrini 2020.AS Pro Kapital Grupp informeerib võlakirjade pakkumise tulemustest eraldi teatega pärast võlakirjade jaotamise otsuse tegemist.Käesolev teade on avaldatud lähtudes “Nõuded Emitentidele” punktist 7.6 ja ei ole käsitletav pakkumisena märkida võlakirju.Allan RemmelkoorJuhatuse liigeTel: 614 4920Email:...